Stock Rating Report for ABMD

Ticker: 

Stock Information

Ticker ABMD
Company Name Abiomed Inc
Current Price $22.70
Previous Close $22.70
Industry Medical Appliances and Equipment
Sector HEALTHCARE
Long Stop Loss Members Only
Short Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

StockProphet Ratings

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

Sector Risks

Sign up for MarketProphet today to see our 30, 60, and 90 day risk assessment for this stock.


Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for ABMD. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Abiomed Inc next week. Sign up today and start making money!

Demand Fundamentals

Demand Fundamental Value Score Rating
Qtr/Qtr Revenue Growth Members Only
Qtr/Qtr Earnings Growth Members Only
Year/Year Revenue Growth Members Only
Year/Year Earnings Growth Members Only
Multi-Year Revenue Growth Members Only
Multi-Year Earnings Growth Members Only
Relative PE Ranking Members Only
Return on Equity Members Only
Yield Members Only
Institutional Holding Members Only
Stock Price Members Only
Relative Fundamental Ranking Members Only
Total Score Members Only

Demand Technicals

Demand Technical Value Score Rating
Recommended Condition Members Only
Trading Zone Members Only
Average Trading Volume Members Only
Industry Bull/Bear Condition Members Only
Sector Bull/Bear Condition Members Only
Current Signal Start Date Members Only
Total Score Members Only

Company Profile

Abiomed, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology- and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers AbioCor implantable replacement heart, a self-contained artificial heart for end-stage biventricular heart failure patients. Further, the company develops Intra-Aortic Balloon, an inflatable balloon inserted through a catheter into the patient's circulation- iPulse- and portable circulatory support driver for in-hospital and out-of-hospital patients. It sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. The company was founded in 1981 and is based in Danvers, Massachusetts.


Latest News

Wed, 08 Feb 2012 00:49:34 GMTAbiomed CEO on Blowout Earnings
Tue, 07 Feb 2012 23:45:00 GMT[video] Abiomed CEO on Blowout Earnings
Mon, 06 Feb 2012 18:18:50 GMTNasdaq stocks posting largest percentage increases
Mon, 06 Feb 2012 14:22:50 GMTNew Star Analyst Rankings for ABIOMED, Inc.
Mon, 06 Feb 2012 13:15:22 GMTAbiomed Tops, Swings to Black
Fri, 03 Feb 2012 21:47:36 GMTFriday?s biggest gaining & declining stocks
Fri, 03 Feb 2012 21:34:17 GMT8 Stocks Soaring on Unusual Volume
Fri, 03 Feb 2012 15:01:37 GMTGappers report: Bullish gaps
Fri, 03 Feb 2012 13:40:08 GMTU.S. Stock Futures Soar as Economy Adds 243K Jobs; Unemployment Rate Slips to 8.3%
Fri, 03 Feb 2012 12:35:35 GMTABIOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Fri, 03 Feb 2012 12:07:15 GMTQ3 2012 Abiomed Inc Earnings Release - Before Market Open
Fri, 03 Feb 2012 12:00:00 GMTAbiomed Reports Record Revenue of $32.2 Million and Earnings of $2.9 Million for Third Quarter of Fiscal 2012
Tue, 31 Jan 2012 13:00:00 GMTNew Clinical Data for Symphony Presented in Late Breaking Clinical Trials Session at the Society of Thoracic Surgeons 2012 Annual Meeting
Mon, 30 Jan 2012 15:28:28 GMT1 Reason to Expect Big Things From Abiomed
Thu, 26 Jan 2012 17:24:16 GMT8 Healthcare Stocks Rated Outperform By Robert W. Baird
Thu, 26 Jan 2012 17:13:00 GMTAbiomed Third Quarter Fiscal 2012 Earnings and Conference Call Notification
Mon, 23 Jan 2012 20:45:31 GMTABIOMED INC Files SEC form 8-K, Change in Directors or Principal Officers
Fri, 20 Jan 2012 18:20:10 GMT10 Top Morningstar M&A Stock Picks for 2012
Thu, 19 Jan 2012 14:00:00 GMTA Forward Look, The Year Ahead - Featured Research on HeartWare International Inc and ABIOMED, Inc.
Wed, 18 Jan 2012 20:21:45 GMTTransocean, Abiomed May See Takeover Interest, Morningstar Says
News provided by Yahoo! Finance
Home | StockProphet | Top 100 Stocks | New Hot Stock Picks | Sector Analyzer | Industry Analyzer | Member's Area | FAQ | Contact Us | Privacy and Security
(C) Copyright CycleProphet, Inc.  All Rights Reserved.

*Past performance does not guarantee future results. CycleProphet makes no representations or warrants that just because a stock would have made a profit in the past, using CycleProphet buy recommendations or sell recommendations, it will make any profits in the future. It is possible that these same stocks will lose money in the future using the CycleProphet stock recommendations.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither CycleProphet nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the CycleProphet site, a user agrees not to redistribute the information found therein.

thinkorswim, Division of TD AMERITRADE, Inc. and CycleProphet are separate, unaffiliated companies and are not responsible for each other's services and products.